Quotient Limited logo
Quotient Limited QTNT

Quarterly report 2022-Q4
added 02-09-2023

report update icon

Quotient Limited Cash Flow 2011-2026 | QTNT

Annual Cash Flow Quotient Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-77.6 M -80.6 M -75.7 M -68.4 M -56.2 M - - - - - -

Depreciation & Amortization

8.8 M 12.5 M 12.7 M 10.3 M 9.38 M 2.86 M 1.18 M 519 K 337 K - -

Accounts Payables

4.66 M 4.83 M 5.94 M 5.44 M 10.8 M 7.29 M 7.24 M - - - -

Accounts Receivables

5.32 M 5.4 M 3.35 M 2.86 M 2.56 M 2.27 M 1.81 M - - - -

Total Inventories

22 M 20.5 M 15.6 M 16.3 M 13.6 M 12.6 M 4.61 M - - - -

All numbers in USD currency

Quarterly Cash Flow Quotient Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- -89.2 M -64.3 M - - -96.2 M -58.7 M -32.1 M - -56.7 M -30.6 M -24.8 M - -64.8 M -42.7 M -25.1 M - -61.5 M -41.1 M - - - -19.1 M - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - - - - - - - 2.34 M 6.43 M 4.09 M - 2.9 M 9 M 6.07 M 3.01 M 3.06 M 9.5 M 6.42 M - 2.58 M 2.59 M 2.46 M - 2.37 M 7.03 M 4.64 M - 643 K 1.57 M 907 K - 316 K 938 K 282 K - - 376 K 240 K - - - - - - - - -

Accounts Payables

2.81 M 3.75 M 5.5 M 4.52 M 3.25 M 5.49 M 4.62 M 4.62 M 5.86 M 5.86 M 5.14 M 5.62 M 3.51 M 3.94 M 5.34 M 5.94 M 3 M 2.64 M 5.37 M 5.44 M 11.3 M 7.48 M 10.1 M 10.8 M 9.46 M 8.18 M 8.61 M 7.29 M 9.24 M 12 M 8.84 M 7.24 M 5.52 M 5 M 6.95 M 5.34 M - - - - - - - - - - - -

Accounts Receivables

6.65 M 5.18 M 5.06 M 6.27 M 6.15 M 5 M 4.45 M 4.45 M 4.54 M 4.54 M 4.52 M 5.97 M 5.04 M 4.33 M 4.72 M 3.35 M 2.36 M 2.51 M 2.88 M 2.86 M 2.02 M 2.46 M 2.8 M 2.56 M 1.64 M 3.95 M 2.36 M 2.27 M 1.48 M 2.12 M 2.21 M 1.81 M 2.01 M 2.65 M 3.23 M 2.44 M - - - - - - - - - - - -

Total Inventories

14.3 M 12.8 M 22.1 M 22 M 22.8 M 25 M 23.2 M 23.2 M 23.7 M 23.7 M 22.8 M 21.3 M 19.8 M 18.1 M 16.7 M 15.6 M 15.3 M 15.3 M 15.6 M 16.3 M 16.5 M 15.2 M 14.8 M 13.6 M 13.2 M 13.4 M 12.8 M 12.6 M 7.81 M 5.83 M 5.01 M 4.61 M 4.59 M 4.42 M 4.64 M 4.56 M - - - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Quotient Limited, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Diagnostics research sector

Issuer Price % 24h Market Cap Country
Agilent Technologies Agilent Technologies
A
$ 110.24 -2.86 % $ 33.5 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Waters Corporation Waters Corporation
WAT
$ 289.16 -3.79 % $ 17.2 B usaUSA
Exagen Exagen
XGN
$ 2.68 -3.94 % $ 57.8 M usaUSA
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
- - $ 19.8 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 16.36 -11.57 % $ 176 M chinaChina
Sotera Health Company Sotera Health Company
SHC
$ 13.13 -3.03 % $ 3.73 B usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 26.78 -1.33 % $ 20 B niderlandNiderland
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 102.08 -0.97 % $ 8.42 B irlandaIrlanda
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.16 0.87 % $ 6.32 M usaUSA
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
DexCom DexCom
DXCM
$ 62.25 -5.81 % $ 24.3 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 23.53 -4.74 % $ 654 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 159.16 -3.62 % $ 7.89 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 195.51 -1.33 % $ 21.7 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
- -2.3 % $ 19.4 M usaUSA
OpGen OpGen
OPGN
- -16.95 % $ 1.54 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
PerkinElmer PerkinElmer
PKI
- -0.91 % $ 14.7 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
$ 1.68 -2.89 % $ 7.37 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Neogen Corporation Neogen Corporation
NEOG
$ 8.7 -4.92 % $ 1.89 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 264.2 -1.56 % $ 22 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
- -1.84 % $ 15.3 M usaUSA
Precipio Precipio
PRPO
$ 25.97 -4.52 % $ 33.7 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 16.78 -3.95 % $ 894 M usaUSA
Syneos Health Syneos Health
SYNH
- - $ 4.46 B usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
- 5.66 % $ 22.7 M britainBritain
VolitionRx Limited VolitionRx Limited
VNRX
$ 0.2 1.87 % $ 19.2 M singaporeSingapore
Bioventus Bioventus
BVS
$ 8.94 -3.46 % $ 596 M usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 4.4 101.83 % $ 129 M usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
- - $ 1.49 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 181.52 -3.27 % $ 129 B usaUSA